Colon cancer screening kits have a high rate of untestable samples
More than 10% of the tests used for routine colorectal cancer screening contained samples that could not be processed by labs.
More than a tenth of fecal immunochemical tests, used for routine colorectal cancer screening, contained samples that could not be processed by labs, according to a study published this week in Cancer Epidemiology, Biomarkers and Prevention, a journal of the American Association for Cancer Research.
This is over twice the amount recommended by the U.S. Multi-Society Task Force, whose guidance says that for such tests the proportion of returned and unprocessed samples should not be more than 5%.
What's Your Reaction?
